key: cord-0764935-o4l65s56
authors: Santiago-Rodriguez, Edda I.; Maiorana, Andres; Peluso, Michael J.; Hoh, Rebecca; Tai, Viva; Fehrman, Emily A.; Hernandez, Yanel; Torres, Leonel; Spinelli, Matthew A.; Gandhi, Monica; Kelly, J. Daniel; Martin, Jeffrey N.; Henrich, Timothy J.; Deeks, Steven G.; Sauceda, John A.
title: Characterizing the COVID-19 illness experience to inform the study of post-acute sequalae and recovery: a qualitative study
date: 2021-03-12
journal: medRxiv
DOI: 10.1101/2021.03.10.21253330
sha: 64d4203e29db7690a04641096ccbe1b308abb452
doc_id: 764935
cord_uid: o4l65s56

We aimed to characterize the variability in the illness experience and recovery process from COVID-19. We conducted in-depth individual interviews with participants enrolled in the Long-term Immunological Impact of Novel Coronavirus (LIINC) cohort study in San Francisco, California from June through October of 2020. Participants were adults who had a previously confirmed positive SARV-CoV-2 nucleic acid amplification test result, had recovered or were recovering from acute infection, and underwent serial evaluations at our clinical research center. We purposefully sampled 24 English- and Spanish-speaking adults with asymptomatic, mild and severe symptomatic infection, including those who were hospitalized, and those with HIV co-infection. Half of our sample (50.0%) identified as Latinx/Hispanic and most of the participants were men (62.5%). We used thematic analysis to characterize the illness experience, recovery process, and mental health impact of experiencing COVID-19 and present clinical data for each participant. Emergent themes were: (1) across symptom profiles and severity, experiencing COVID-19 was associated with psychological distress, (2) among participants with symptomatic infection, the illness experience was characterized by uncertainty in terms of managing symptoms and recovery, and (3) despite wide-ranging illness experiences, participants shared many common characteristics, including health information-seeking behavior facilitated by access to medical care, and uncertainty regarding the course of their illness and recovery. COVID-19 was associated with elevated levels of psychological distress, regardless of symptoms.

There is an urgent need to understand the impact and optimal management of the variability in the disease experience and recovery from post-acute sequelae of SARS-CoV-2 infection (PASC). 1 Our early understanding of the lived experiences and challenges with recovery from COVID-19 was mainly from reports in media outlets, [2] [3] [4] [5] and editorials, letters, and case reports in scientific journals. [6] [7] [8] While these reports and editorials highlight unique disease experiences and areas to prioritize for future research, they do not leverage data from personal experiences with COVID-19 through formal qualitative research. Such research methods can characterize the variability in how people define and experience their disease and recovery, 9 which can offer insights to optimize management of persistent symptoms of COVID-19.

COVID-19 has produced wide-ranging physical, neurological and mental health effects, many of which are yet to be fully understood, 10, 11 leaving many individuals in a state of uncertainty. However, there are lessons that can be drawn from research on chronic disease management where prognoses are uncertain, such as the potential benefits of informationseeking behavior 12 and leveraging a person's healthcare empowerment, 13 both of which describe how individuals process, understand, seek and act on disease information, especially for coping with uncertainty and chronic disease. 14, 15 In this regard, qualitative research methods are a useful approach to characterize the processing of the COVID-19 diagnosis, illness experience, and recovery process. 16 Furthermore, characterizing the illness experience and recovery trajectory in persons with a history of COVID-19 may inform the management of post-acute sequalae given the uncertainties that remain regarding its pathogenesis and emerging evidence that not all individuals experience a rapid or complete recovery.

Objective . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021. ;  https://doi.org/10.1101/2021.03. 10.21253330 doi: medRxiv preprint We conducted in-depth interviews with a diverse group of people with previously documented SARS-CoV-2 infection who had entered the "recovery phase" from COVID-19 and were able to attend at least one in-person visit at our study center. The group included persons who had experienced a spectrum of severity of the acute SARS-CoV-2 illness, including those who had asymptomatic infection, mild disease, and severe disease requiring hospitalization. We also included people with co-infections, such as people living with HIV (PLWH). We were interested in examining the spectrum of lived experiences following COVID-19 diagnosis.

Participants in this study were enrolled in a parent cohort study, the Long-term Immunological Impact of Novel Coronavirus (LIINC) COVID-19 recovery cohort study. 17 LIINC explores immunologic responses at different stages of convalescence to understand the effects of SARS-CoV-2 over time, and is based within an academic care and research center in an infectious diseases division at the University of California, San Francisco (UCSF). The clinical course for each participant interviewed will be provided to contextualize the participant interview data from this qualitative study.

The University of California, San Francisco Committee on Human Research reviewed and approved the parent study (LIINC) and this qualitative study. All participants in the parent study signed a written informed consent and provided written consent to be referred to participate in this qualitative study. Participants provided verbal consent for the interview and written consent for review of their clinical data.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Participants from the LIINC study were then enrolled in this separate qualitative study if interested.

Clinical staff provided a general overview of the qualitative study to LIINC participants; willing participants were then referred to the social science research team who conducted this study. A total of 42 participants were referred by the LIINC staff. The social science research team contacted potential participants through email, phone call, or text message based upon their . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21253330 doi: medRxiv preprint stated preferences. Participants who were reached and available to participate were scheduled for a semi-structured in-depth interview through privacy-compliant video conference software or telephone. We used a purposeful sampling method by having weekly discussions with the LIINC team during active enrollment about the demographic characteristics of their referrals based on ethnicity/race, HIV status, language and occupation. The purpose of this sampling strategy was to ensure that diverse COVID-19 experiences and participant demographic characteristics were captured.

Interviews were conducted between June and October 2020. Interviews were of 30 to 90 minutes in duration and were conducted in English or Spanish by two fully bilingual qualitative researchers. The semi-structured interview guide was designed to explore areas related to COVID-19 such as: knowledge, prevention methods, symptoms, testing experiences, different recovery experiences, access to resources, housing stability, food insecurity and economic stability. Interviews were audio-recorded and transcribed ad verbatim. After the interview, each participant received a $50 gift card. We interviewed until saturation was evident (redundancy in narratives, no new insights), which occurred after 24 interviews.

We used thematic analysis 18, 19 to systematically identify and organize patterns of meanings throughout a set of interview transcripts. A thematic analysis serves as a flexible method for explorative studies like this where you don't have a clear idea of what theme patterns you are searching for in the data. All interview transcripts were uploaded onto Dedoose, a webbased program to organize and manage qualitative data. 19 Two authors (EIS and AM) then reviewed a subset of two transcripts to identify initial impressions and develop an initial codebook. The codebook was developed using deductive and inductive codes based on the . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21253330 doi: medRxiv preprint interview questions and themes emerging from the interviews. Each transcript was coded by a bilingual primary coder (social and community psychologist) and reviewed by a bilingual secondary coder (medical anthropologist). For this analysis, we reviewed the coded texts in their original language related to symptoms, treatment and recovery experiences among participants.

(English translation of Spanish quotes is provided for transparency and original meaning). The team then had periodic sessions approximately every other week for two months to discuss and summarize the texts. Emerging and preliminary results were discussed with the senior author (health psychologist) and one of the LIINC co-principal investigators (infectious disease physician and researcher).

We also summarized clinical evaluation data from participants' initial LIINC visit. These data were anonymized to protect confidentiality and are presented below participants' first quotes to help contextualize their narratives. We present self-reported demographic information, exposures, symptoms, symptom onset and severity, presence of persistent symptoms, and treatments administered for COVID-19, and mental health during their illness course. For asymptomatic infections, we report the date of the positive SARS-CoV-2 test result, whereas for symptomatic infection, we report date of symptom onset. The clinical evaluation also asked participants with symptomatic infection to volunteer to rate how good/bad their health during the worst point of illness with COVID-19, from 0 (worst) to 100 (best). We labeled this score their health score. For participants with asymptomatic infection, the health score represents how good/bad their self-perceived health was immediately before their positive test result. Not all participants chose to answer all clinical evaluation questions, which is denoted by the phrase "none reported."

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 12, 2021 

Twenty-four individuals participated in the qualitative study. The median patient age was 49 and most of the participants were men (62.5%) and white (66.7%). Half of our sample (50.0%) identified as Latinx/Hispanic. Nine participants reported they were hospitalized due to COVID-19, six of whom required oxygen support. Out of the nine, three were transferred to the intensive care unit, and two were intubated. Eight participants were living with HIV. Six participants completed the interview in Spanish.

We started all interviews by asking about how participants learned about COVID-19 at the start of the pandemic and where they sourced their information. We then transitioned to discussing participants' experiences with COVID-19, the emotional impact of having a confirmed COVID-19 diagnosis, and the factors influencing the recovery process. To protect confidentiality, we report participants by identification numbers and modified data (e.g., dates) to maximize confidentiality.

Importantly, although some participants were categorized as having asymptomatic infection, they described deep concern over their diagnosis and uncertainty with potential illness and highlighted the benefits of having support and access to medical care. Participant #8, whose health score was 65/100 before diagnosis, stated that his experience with COVID-19 was informed by living with HIV and other comorbidities. His access to HIV care provided a source of information and support since he expected to be at high risk for COVID-19 disease based on his medical history. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 12, 2021 Another factor in their recovery was how participants could actively benefit from their health information-seeking behavior by having access to medical care and providers. Similarly, participant #24, a Spanish-speaking woman and caregiver to her two children who had serious medical conditions, and whose health score was 70/100 before her diagnosis, described the support she had by having access to a medical team after testing positive for SARS-CoV-2 prior to surgery. The following quote also highlights how she actively sought COVID-related health information. After receiving her diagnosis, participant #24 explained that her primary care provider also offered her support as she anticipated the onset of illness symptoms.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 For health information-seeking behavior to benefit a person, it must result in a change in outcomes, such as new knowledge gained or receipt of support, both of which were present in the narratives of participants #8 and #24. For example, when participant #8 stated he sent multiple emails to his HIV medical provider to follow up on his original inquiry, he was able to receive moral support. His information seeking also led to his awareness of ongoing discussions of whether antiretroviral therapy was offering protection to people living with HIV.

"I heard people saying people who are on lots of antivirals, like myself, weren't getting it as readily, but I don't know the facts behind that..."

Despite the reassurances that participant #8 received about his risk for severe COVID-19 symptoms because he was living with HIV, he was also aware of his risk for severe COVID-19 due to his diabetes.

In documenting the "recovery" process from asymptomatic infection, the importance of social support was also evident throughout the participants' experiences. As participant #8 stated:

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 Participant #8 expressed concern about his asymptomatic infection considering other serious medical conditions he had experienced before. "I'm not a fearful person. I've almost died a couple of times, so nothing really bothers me or frightens me. But this is a little scary…I was afraid. I was concerned with getting it because I've had all those infections."

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 Both participants #17, a middle-aged female (did not report a health score) who required hospitalization, and participant #21, who reported a health score of 60/100, took their initial . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 Two additional participants, #6 and #7, reported similar symptoms to those mentioned directly above, but also suffered from shortness of breath, loss of taste and smell, and extreme exhaustion. Participants #6 and #7 provide insights into the rapid onset of severe illness and a feeling of getting "hit like a train" all at once unexpectedly.

"I flew down…to visit my friend…and I was completely fine. There were no preceding symptoms. And then I woke up the next day and I felt like various symptoms like I had a fever, I couldn't walk properly, I couldn't taste or smell anything. It all just kind of came at once. There was no, like, leading up to. You know, feeling symptoms of cold, you kind of feel that something is coming on, but this, it just hit me like a train; all at once. All these symptoms came up all at once and they were very severe -shortness of breath, everything."

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The experiences of participants #4 and #14 highlight the severity and burden of managing persistent COVID-19 symptoms. While the clinical evaluation data show overlapping symptoms across all the participants quoted above, their experiences were variable but intense. One common thread was confusion and uncertainty -either from processing the rapid onset of severe symptoms with their initial diagnosis or concerns regarding cognitive impairment following recovery from the acute process. While we did not capture full information on the burden of managing symptoms that persisted at the time of the interview, we characterize the initial experience as very burdensome, including ongoing uncertainty among several participants. In the next section, we characterize the experiences of people who accessed medical care for COVID-

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 Common experiences among participants hospitalized were clear gaps in memory, confusion, and other neurological features, including persistent symptoms of trouble concentrating, headaches, and loss of sense of smell. The consequences of these experiences remain unknown, but warrant further investigation to determine the management and recovery process of participants with severe acute disease and persistent symptoms.

COVID-19 affected the mental health of all participants, including participants with asymptomatic infection. This was attributed by both asymptomatic and symptomatic participants to either the uncertainty behind their diagnosis, symptom course, the initial severity of symptoms for some, the fear of dying, and concern for the health of family and friends. In some instances, predisposition to experience psychological distress were catalyzed by COVID- 19 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 Participant #5 shared his struggle with depression, compounded by the process of social isolation due to his diagnosis. His fear of dying alone led to a psychiatric emergency requiring hospitalization.

"When I was sick I had the news on a lot, mostly just CNN. I had been isolating before. I mean, I didn't do a great job at the sheltering in place. But when I had to self-isolate because I was ill, I had to shut myself from anybody. Any food I had [was] delivered and, so, I had no reasons to go outside. So, I started to get depressed. And this is going to sound silly because you'd have to be in my head to understand, but I was really feeling sad…everything was compounding, like just with the news…I kept thinking I'm going to die. No one's seen me, nobody cares that they can't see me. So, I called…911 -well, there was the non-emergency number, but they did come and then they took me to the emergency [room] . And it was funny because one of the EMTs, whatever, he asked me what's wrong. I said, 'well, I really feel sad.' He said: 'Okay. We're going to take you in for sadness?' I said: 'Well, it sounds funny because the way you're saying it, but yeah, really I am'" Participant #5: Older adult, Latinx male. Exposure: Community spread. Symptom onset: April 2020. Symptoms: Fever, chills, fatigue, cough, shortness of breath, sore throat. Persistent symptoms: None. Health score: None reported. Mental Health: Not reported. Treatment: None.

Participant #6 (described above) described feeling anxiety and frustration over his recovery process:

"At that point I was, like, I probably have it. But as far as recovering, that's what I was more worried about; like, when is this going to be over? Like I don't feel I'm getting better. If anything, I'm declining. So, it was more of like a feeling of anxiousness and, like, frustration." . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21253330 doi: medRxiv preprint Levels of stress, anxiety and frustration among participants could be directly related to the fear of dying or uncertainty pertaining to the health consequences of COVID-19. Participant #14 (described above) shared that he could identify the symptoms and knew it was COVID-19, and mainly worried about the possible progression of his situation:

"I knew that I had it probably. I guess, I don't know, it's just like, 'Okay.' At that time, I would have been a lot scared now because we know how crazy it can be and then people fall off a cliff. We didn't know any of that back then, so I was like, 'You know, as long as I'm not dying then I guess I'm not dying'…I was worried because I had done enough research to understand that the receptors where your taste, where your smell, are very close to the brain and the central nervous system so it's like, ' Oh God, what if it gets into my brain. We don't know anything about this.'"

As the parent study was housed within an HIV care and research center, we were able to recruit people into this study who were living with HIV and recovered from COVID-19. Most of the participants living with HIV were very attuned to early concerns of being at higher risk for severe COVID-19, although the fear of having more severe outcomes in this population attenuated over time with more data. Overall, participants noted that the fact that they were living with a co-infection of HIV facilitated them seeking information, staying vigilant, and following public health guidelines.

Participant #23 stated feeling very fortunate, despite "my condition" [HIV] , having had a few critical days when he felt deep anguish ("con mucha angustia"), and compared himself to other people of different ages he knew or had heard of that died of COVID-19, including two family members in Mexico.

Participant #23: Older adult, Latinx gay male. Exposure: Community spread. Symptom onset: July 2020. Symptoms: Fever, chills, fatigue, cough, shortness of breath, sore throat, muscle aches, loss sense of smell, headaches, irritability. Persistent symptoms: Headache. Health score: 50 out of 100. Mental Health: Moderately anxious and depression during illness. Treatment: None reported.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21253330 doi: medRxiv preprint Participant #5 (described above) felt at higher risk because of his HIV status and additional comorbidities: "I kept thinking I was one of the ones that if you got it, it's really not going to look good for you. I've had two heart attacks. I have HIV…viral load is not so great. Yeah, just didn't think it would bode well for me to have the COVID- 19." He explained that usually he struggled with adherence to his HIV treatment but that while recovering from COVID-19, he tried to regularly take his medications "with a purpose", having heard on the news that antiretrovirals may have a protective effect. Participant # 10 explained that he initially had nose bleeds and headaches, but not having seen those in the list of COVID-19 symptoms, he did not call his HIV provider because he was afraid he would be told he had COVID-19. However, he acknowledged that he could have addressed this concern if he had contacted his HIV care provider.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 Participant #10 expressed the feeling of being afraid of dying from COVID-19, but the support from his neighbors and friends, his family to some extent, and knowing that a person delivering food from Meals on Wheels (non-profit organization providing food assistance) was on the other side of his closed door, sustained him during his recovery process. He explained that his family was concerned for him but qualified his family support by saying they did not know how to deal with a crisis and had asked him whether he had made "arrangements" in preparation for his death. He noted that he only recently disclosed his HIV status to his family, which may have influenced their reaction. Like all participants in our study, participant #10 was trying to reconcile uncertainty around immunity and risk of re-infection, which was yet to be determined in the scientific literature at that time. Like other participants, he was actively seeking health information through a local and well-known HIV-related institution in San Francisco. Further, he deliberated over whom to tell he had had COVID-19 in anticipation of community stigma. He emphasized the . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021 In summary, participants who had been living with HIV had a heightened awareness of the risks for severe COVID-19 disease, drew lessons for coping from the HIV epidemic, and also displayed high levels of health information-seeking behavior, in part due to their engagement in HIV care. Critical lessons can be learned from the participants in this study related to . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21253330 doi: medRxiv preprint management of persistent symptoms with COVID-19, ensuring easy access to health information and wrap-around service support, including mental health support.

Our qualitative data from English-and Spanish-speaking individuals with a past diagnosis of COVID-19 across a variety of disease presentations illustrate the challenges of understanding and evaluating the variability in the illness and recovery experience with COVID-19. Overall, three findings emerged that were central to the acute experience with COVID-19 that we believe may be useful for research on post-acute sequalae of COVID-19. First, all individuals had to manage pervasive uncertainty in multiple domains, including processing the possible consequences of asymptomatic infection; uncertainty regarding the course following symptomatic infection in terms of cognitive function and memory loss; and the ongoing recovery process, especially among those requiring hospitalization. Second, given that COVID-19 is a novel disease, we found high levels of health information-seeking behavior (e.g., calling medical providers, sources of trusted information). Importantly, information-seeking behavior served as a proactive coping strategy for managing the unpredictability of the illness at the time and facilitated by access to medical care. The resulting information-sharing participants received from medical staff and providers led to receipt of instrumental, moral, and social support. Lastly, despite different symptom profiles and severities, all participants shared similar levels of psychological distress, likely through the underlying uncertainty they were attempting to cope with both related to COVID-19 and related scenarios (e.g., implications for other medical conditions, concerns for family, mental health).

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Recently established cohort studies show that common symptoms among people with post-acute sequalae from COVID-19 are frequently non-specific: fatigue, myalgias-arthralgias, and neurological (i.e., headaches, "brain fog"), 7, 21, 22 suggesting that managing patient uncertainty will be a part of the overall coping process and management. Our data shed light on the intensity of the illness experience, even across initial symptom strata, and suggest that psychological adjustment will be key in recovery. While neurocognitive post-acute sequalae is an emerging and less understood area, 23 there may be implications for these sequalae exacerbating psychological distress resembling post-traumatic stress (i.e., arousal, worry, intrusive thoughts) given many participants had near-death experiences. [24] [25] [26] [27] But importantly, in identifying frameworks to help understand the experience of a new disease with a high degree of uncertainty, we found lessons can be drawn from management of chronic diseases (e.g., pulmonary disease, liver disease, and HIV).

Our data regarding how participants processed and coped with their illness showed similarities to the dimensions of the healthcare empowerment model, originating out of work in HIV, cancer, and cardiovascular disease. This model outlines that coping with a novel disease such as COVID-19 will require navigating a level of uncertainty, which can be managed by supporting actions to stay informed and engaged with a treatment plan and team. 13, 28 Other research from pulmonology and gastroenterology, 29,30 including interventions and qualitative research, points to use of cognitive and behavioral strategies to manage psychological distress over the unpredictability of illness and prognoses, and recommends communication with healthcare providers about their own clinical uncertainties. As participants' experiences highlighted, there will be a need to provide information and continuous support to persons with post-acute sequalae to ensure they feel secure along the path to recovery.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21253330 doi: medRxiv preprint

Our study has several limitations. First, it was completed amid the first two waves of COVID-19 cases in the United States, and new information and details about the virus, symptoms, treatments and sequelae were evolving daily. Second, our participants were engaged in the start of a newly developed cohort study; these engaged participants may differ from other populations of individuals who have recovered from COVID-19. Because the study took place in an infectious disease (including HIV) care and research center in San Francisco, which took aggressive measures to shelter-in-place earlier than other major cities, and many participants were already linked to the medical setting formally, there are likely differences in experiences compared to persons with limited access to medical care. And while we presented clinical evaluation data alongside selected quotes, these data were not used or reviewed by interviewers at the time of the interviews and thus, we are limited in our ability to integrate these data with our qualitative data. However, given the patterns that emerged across all narratives, we have no reason to believe that the results depend on other characteristics of the participants or context.

We conducted a qualitative study of individuals who had recovered or were recovering from COVID-19 with wide-ranging experiences. We were able to leverage personal narratives of experiences with asymptomatic infection, symptomatic infection, including hospitalization, and HIV co-infection, to identify patterns in how the disease was experienced and gain insights into the recovery process. Psychological distress was elevated regardless of symptomatology.

Information-seeking behavior, health empowerment, and social support were enabling factors toward recovery for our participants. These data may help shed light on the management of . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21253330 doi: medRxiv preprint emerging post-acute sequalae of COVID-19, including addressing issues with disease uncertainty, mental health, and persistent symptoms.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21253330 doi: medRxiv preprint

NIH Director's Blog. Post-acute sequalae of COVID-19

Another scary thing about COVID: Survivors aren't fully recovering

When symptoms of COVID-19 don't go away

Long-haulers are redefining COVID-19. The Atlantic

Almost a third of people with 'mild' COVID-19 still batter symptoms months later, study finds. CNN Health

My experience with COVID-19 -not just another experience

& for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19

Mild or moderate COVID-19

Qualitative research: Qualitative Research: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research

Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science

Management of post-acute covid-19 in primary care

Health Information-Seeking Behavior. Qualitative Health Research

The shifting landscape of health care: toward a model of health care empowerment

Empowerment in healthcare: a thematic synthesis and critical discussion of concept analyses of empowerment

COVID-19 Information Seeking on Digital Media and Preventive Behaviors: The Mediation Role of Worry

Methods in the Time of COVID-19: The Vital Role of Qualitative Inquiries

Impact of Infection with Novel Coronavirus (LIINC) study website

Applied Thematic Analysis

Thematic analysis and its reconceptualization as "saliency analysis

Dedoose Version 7.0.23, web application for managing, analyzing, and presenting qualitative and mixed method research data

Sequelae in Adults at 6 Months After COVID-19 Infection

Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors

COVID-19 pandemic and mental health consequences: Systematic review of the current evidence

Traumatic stress in the age of COVID-19: A call to close critical gaps and adapt to new realities

Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors

Healthcare empowerment and HIV viral control: mediating roles of adherence and retention in HIV care

We are grateful to the LIINC study participants and to the clinical staff who provided care to these individuals during their acute illness period. We acknowledge LIINC clinical study team members: Tamara Abualhsan, Mireya Arreguin, Jennifer Bautista, Monika Deswal, Heather Hartig, Marian Kerbleski, Sadie Munter, Fatima Ticas, and Meghann Williams. We acknowledge LIINC leadership team members Bryan Greenhouse, Isabel Rodriguez-Barraquer, and Rachel Rutishauser.